InvestorsHub Logo

researcher59

12/22/14 8:34 AM

#164556 RE: wadegarret #164545

AMOT balance sheet is fine. The big question is whether Q3 will repeat or improve in Q4. Synergies with the big acquisition may be completed. Book to bill only modestly positive. I don't think there's much seasonality.

My price target is $25+.